Abstract
Background
The aim of the study is to demonstrate the participation of the inflammatory-immune process in the pathogenesis of proliferative diabetic retinopathy (PDR).
Methods
Twenty four women and 22 men with type 2 diabetes (mean age 63.97 ± 9.00 years, mean duration of diabetes 12.56 ± 6.87 years) were enrolled in the study. Serum concentrations of soluble forms of ICAM-1, VCAM-1 as well as IL-6 and TNF-α were evaluated in all study subjects. In 19 patients, simultaneous assessment of selected parameter levels in both serum and vitreous samples was performed. Vitrectomy was performed due to intravitreal hemorrhage, accompanied in some patients by traction retinal detachment. The control group consisted of 15 patients having undergone vitrectomy for reasons other than PDR. Tests were performed using the ELISA method.
Results
Serum and intraocular concentrations of sICAM-1, sVCAM-1, IL-6, TNF-α were considerably higher in study subjects with PDR than in controls. Simultaneously, a positive correlation was found between intraocular sVCAM-1 (r = 0.590, p = 0.007), TNF-α (r = 0.822, p < 0.001) concentrations and HbA1c levels. The above-mentioned dependence was not shown for sICAM-1 and IL-6 vitreous concentration. Local vitreous VCAM-1 level increase was also dependent on vitreous TNF-α concentration growth (r = 0.470, p = 0.043). No significant correlation was found between serum and vitreous levels of the selected parameters in the group of 19 patients with PDR.
Conclusions
Increase in sICAM-1 and sVCAM-1 levels, as well as their correlation with high vitreous IL-6 and TNF-α concentrations in patients with PDR, seem to confirm the inflammatory–immune nature of this process. In diabetes, inadequate metabolic control remains an important risk factor in the development of PDR.
Similar content being viewed by others
References
Abiko T, Abiko A, Clermont AC (2003) Characterization of retinal leukostasis and hemodynamics in insulin resistance and diabetes. Diabetes 52:829–837
Adamis AP (2002) Is diabetic retinopathy an inflammatory disease? Br J Ophthalmol 86:363–365
Barouch FC, Miyamoto K, Allport JR, Fujita K, Bursell SE, Aiello LP et al (2000) Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes. Invest Ophthalmol Vis Sci 41(5):1153–1158
Doganay S, Evereklioglu C, Er H, Turkoz Y, Sevinc A, Mehmet N et al (2002) Comparison of serum NO, TNF-α, IL-1β, sIl-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus. Eye 16:163–170
Hernandez C, Burgos R, Canton A, Garcia-Arumi J, Segura RM, Simo R (2001) Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control study. Diabetes Care 24(3):516–521
Matsumoto K, Sera Y, Ueki Y, Inukai G, Niiro E, Miyake S (2002) Comparison of serum concentrations of soluble adhesion molecules in diabetic microangiopathy and macroangiopathy. Diabet Med 19(10):822–826
Olson JA, Whitelaw CM, McHardy KC, Pearson DWM, Forrester JV (2002) Soluble leucocyte adhesion molecules in diabetic retinopathy stimulate retinal capillary endothelial cell migration. Diabetologia 40:1166–1171
Adamiec J, Oficjalska-Młyńczak J (2005) The role of cellular adhesion molecule in the development of proliferative diabetic retinopathy. Acta Ophthalmologica Polonica 107(4–6):330–333
Kao PC, Wu TJ, Ho LL, Li XJ (2000) Current trends and new approaches in the management of diabetes mellitus. Ann Clin Lab Sci 30:339–345
Meleth AD, Agrón E, Chang CC, Reed GF, Arora K, Byrnes G, Csaky KG, Ferris FL, Chew EY (2005) Serum inflammatory markers in diabetic retinopathy. Invest Ophthalmol Vis Sci 46:4295–4301
Limb GA, Chignell AH, Green W, LeRoy F, Dumonde DC (1996) Distribution of TNF alpha and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol 80(2):168–173
Van Seventer GA, Shimizu Y, Horgan KJ, Shaws S (1990) the LFA-1 ligand ICAM-1 provides an important costimulatory signal for T-cell receptor-mediated activation of resting T cells. J Immunol 144:4579–4586
Altmann DM, Hogg N, Trowsdale J, Wilkinson D (1989) Cotransfection of ICAM-1 and HLA-DE reconstitutes human antigen-presenting cell function in mouse L cells. Nature 338:512–514
Dougherty GJ, Murdoch S, Hogg N (1988) The function of human intercellular adhesion molecule-1 (ICAM-1) in the generation of an immune response. Eur J Immunol 18:35–39
Cukiernik M, Hileeto D, Evans T, Mukherjee S, Downey D, Chakrabarti S (2004) Vascular endothelial growth factor in diabetes induced early retinal abnormalities. Diabetes Res Clin Pract 65(3):197–208
Eastern and Southern European Region (2000) Recommendations for the management of patients with type 2 diabetes mellitus in the Central. Int Journ Postgraduate Train Med 8
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ (2003) Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42(6):1206–1252
Schalkwijk CG, Chaturvedi N, Twaafhoven H, Van Hinsbergh VW, Stehouwer CD (2002) Amadori-albumin correlates with microvascular complications and precedes nephropathy in type 1 diabetic patients. Eur J Clin Invest 32:500–506
Schram MT, Chaturvedi N, Schalkwijk C, Giorgino F, Ebeling P, Fuller JH et al (2003) Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes. Diabetes Care 26:2165–2173
Monaco C, Paleolog E (2004) Nuclear factor κB: a potential therapeutic target in atherosclerosis and thrombosis. Cardiovasc Res 61:671–682
Schalkwijk CG, Stehouwer CDA (2005) Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci 109:143–159
American Diabetes Association (2004) Clinical practice recommendations. Diabetes Care 27(Suppl.1)
Bagg W, Ferri C, Desideri G, Gamble G, Ockelford P, Braatvedt GD (2001) The influences of obesity and glycemic control on endothelial activation in patients with type 2 diabetes. J Clin Endocrinol Metab 86:5491–5497
Klein R, Klein BEK (2002) Blood pressure control and diabetic retinopathy. Br J Ophthalmol 86:365–367
Zhang LY, Krzentowski GA, Lefebvre PJ (2001) Risk developing retinopathy in diabetes control and complications trial type 1 diabetic patients with good and poor metabolic control. Diabetes Care 23:1275–1279
Freyberger H, Brocker M, Yakut H, Hammer J, Effert R, Schifferdecker E (2002) Increased levels of platelet-derived growth factor in vitreous fluid of patients with proliferative diabetic retinopathy. Exp Clin Endocrinol Diabetes 108:106–109
Matz R (2000) The target for good glycemic control should be an HbA1c concentrations of less than 0.07. West J Med 173:179–180
Őzmen B, Boyvada S (2003) The relationship between self-monitoring of blood glucose control and glycosylated haemoglobin in patients with type 2 diabetes with and without diabetic retinopathy. J Diabetes Complications 5:186–192
Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA et al (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35). BMJ 321:405–412
Van Leiden HA, Dekker JJ, Moll AC, Nijpels G, Heine RJ, Bouter LM et al (2002) Blood pressure, lipids, and obesity are associated with retinopathy. Diabetes Care 25:1320–1325
Stratton IM, Kohner EM, Aldington SJ, Turner RC, Holmann RR, Manley SE et al (2001) UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia 44:156–163
Author information
Authors and Affiliations
Corresponding author
Additional information
We disclose commercial or similar relationships to products or companies mentioned in or related to the subject matter of the article being submitted.
We have full control of all primary data and we agree to allow Graefe’s Archive for Clinical and Experimental Ophthalmology to review our data if requested.
Rights and permissions
About this article
Cite this article
Adamiec-Mroczek, J., Oficjalska-Młyńczak, J. Assessment of selected adhesion molecule and proinflammatory cytokine levels in the vitreous body of patients with type 2 diabetes — role of the inflammatory–immune process in the pathogenesis of proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 246, 1665–1670 (2008). https://doi.org/10.1007/s00417-008-0868-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-008-0868-6